| Premier Family Care Arab Llc | |
|
20 S Main St Arab AL 35016-1378 | |
| (256) 586-2324 | |
| Not Available |
| Full Name | Premier Family Care Arab Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 20 S Main St, Arab, Alabama |
| Authorized Official Name and Position | Jess H Youngblood (OWNER) |
| Authorized Official Contact | 2565862324 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Premier Family Care Arab Llc 20 S Main St Arab AL 35016-1378 Ph: (256) 586-2324 | Premier Family Care Arab Llc 20 S Main St Arab AL 35016-1378 Ph: (256) 586-2324 |
| NPI Number | 1245614049 |
|---|---|
| Provider Enumeration Date | 07/13/2015 |
| Last Update Date | 01/30/2024 |
| Medicare PECOS PAC ID | 1658671839 |
|---|---|
| Medicare Enrollment ID | O20151207002561 |
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245614049 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Jess H Youngblood |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467676676 PECOS PAC ID: 4688767650 Enrollment ID: I20070906000796 |
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
| Provider Name | Larry R Johnston |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1023003019 PECOS PAC ID: 2961694740 Enrollment ID: I20101012000813 |
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
| Provider Name | John Paul Mizelle |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174099279 PECOS PAC ID: 9739426321 Enrollment ID: I20190118002655 |
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
| Provider Name | Kimberly J Self |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932619236 PECOS PAC ID: 9335479799 Enrollment ID: I20190926003557 |
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
News Archive
CME Medical, is urging hospices to improve their patient safety as part of Hospice Care Week (Oct 7-13) by making the transition from using older ambulatory syringe drivers to using its own T34TM Ambulatory Syringe Pump, to help meet National Patient Safety Agency (NPSA) guidance.
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced that detailed data from its open-label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH) will be presented at the 30th World Congress of the Société Internationale d'Urologie Conference.
Non-alcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver unrelated to alcohol abuse or other liver diseases. It is often associated with obesity and diabetes and is considered a manifestation of metabolic syndrome.
› Verified 8 days ago
Marshall Primary Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 131 Golfview Dr Ne, Arab, AL 35016 Phone: 256-640-8416 Fax: 256-640-8450 | |
Premier Family Care Arab Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 20 S Main St, Arab, AL 35016 Phone: 256-960-9906 | |
The Porch Clinic Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1518 N Brindlee Mtn Pky, Arab, AL 35016 Phone: 256-586-1380 Fax: 256-586-8364 | |
Morgan Family Practice, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 141 Golfview Dr Ne, Arab, AL 35016 Phone: 256-586-1212 Fax: 256-931-2270 | |
John B Crider, Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1170 N Main St, Arab, AL 35016 Phone: 256-586-4127 Fax: 256-586-0535 | |
Robert W Hargraves Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 121 Golfview Dr Ne, Arab, AL 35016 Phone: 256-586-1900 Fax: 256-931-0781 |